Carlos Sagebien, MD

GRANTS/ CLINICAL TRIALS INVESTIGATOR

A Randomized Controlled Trial of Regional Versus General Anesthesia For Promoting Independence After Hip Fracture (REGAIN TRIAL). A multicenter randomized controlled trial to compare survival, functional recovery, cognitive outcomes, and postoperative adverse events among patients aged 50 and older receiving spinal versus general anesthesia for hip fracture surgery. Co-Investigator.

A Phase 2, Multicenter, Single-Blind, Randomized, Stratified, Standard-of-Care Controlled, Feasibility and Safety Study of rhBMP-2/CPM as an Adjuvant Therapy for Fractures of the Proximal Femur. Sponsored by Wyeth Pharmaceuticals, Inc. Co-Investigator.

A Phase 2 / 3, Multicenter, Double-Blind, Randomized, Controlled Study of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP‑2)/Calcium Phosphate Matrix (CPWM) in Closed Diaphyseal Tibial Fractures. Sponsored by Wyeth Pharmaceuticals, Inc. Co-Investigator.

MEMBERSHIPS

• American Academy of Orthopaedic Surgeons (AAOS)
• Orthopaedic Trauma Association (OTA)
• New Jersey Orthopaedic Society (NJOS)
• Eastern Orthopaedic Association (EOA)
• Team Physician, Team USA, World Junior Rowing Championships, Eton, Great Britain, 2011
• Orthopaedic Trauma Consultant: Princeton University, Rider University, Rutgers University

EXAMINATIONS/LICENSURE

• Board Certification in Orthopaedic Surgery: 2007. Recertification 2017: 98^th percentile.
• Orthopaedic National Written Board Examination, July, 2004: Pass – 92^nd percentile.
• Orthopaedic In-service Training Examination, 1999-2003: 92^nd – 100^th percentile.
• United States Medical Licensing Examinations I-III: Pass.
• Maryland State Medical License, 2004-2005
• New Jersey State Medical License, 1999-Present

Dr. Carlos Sagebien, MD was named a Bone and Joint Select Surgeon in 2019 by New Jersey Monthly magazine.